LKFT · Lakefront Biotherapeutics NV
$27.72
-0.43 (-1.53%)
At close · Jul 29
Market Cap
$1.82B
Shares
65.48M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-08-10 00:00 UTC | Half Year 2026 results | Event |
| 2026-11-12 00:00 UTC | Third quarter 2026 results | Event |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-06 | First quarter 2026 results | Event |
| 2026-04-28 | Annual Shareholders’ meeting | Shareholder meeting |
| 2026-03-31 | Conference Call | Conference |
| 2026-03-02 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-24 | Full year 2025 Results | Event |
| 2025-11-19 | Jefferies 2025 London Healthcare Conference | Conference |
| 2025-11-06 | Q3 2025 Results | Event |
| 2025-05-21 | RBC Capital Markets Global Healthcare Conference | Conference |
| 2025-04-29 | Annual Shareholders’ Meeting | Shareholder meeting |
| 2025-04-24 | Q1 2025 Results | Event |
| 2025-04-03 | Kempen Life Sciences Conference | Conference |
| 2025-03-27 | Annual Report 2024 | Event |
| 2025-03-11 | Barclays Global Healthcare Conference | Conference |
| 2025-03-03 | TD Cowen 45th Annual Healthcare Conference | Conference |
| 2025-02-13 | FY 2024 Results | Event |
| 2025-01-13 | J.P. Morgan Healthcare Conference | Conference |
| 2025-01-08 | Galapagos 2025 Business Update | Event |
| 2024-12-17 | KBC Bolero site visit | Event |
| 2024-12-10 | Deutsche Bank C-level Call | Event |
| 2024-11-19 | Jefferies Healthcare Conference | Conference |
| 2024-10-31 | Q3 2024 Results | Event |
| 2024-09-26 | KBC Life Sciences Conference | Conference |
| 2024-09-05 | Morgan Stanley Global Healthcare Conference | Conference |
| 2024-08-02 | H1 2024 Results | Event |
| 2024-06-25 | KBC site visit Leiden | Event |
Source: https://lakefrontbio.com/press-releases/investor-relations-update-fall-2009/
Key facts
CIK
1421876
CUSIP
36315X101
13F (30d)
16 filings
14 filers
Visit website
Investor relations